View Article

  • Therapeutic Effect Of Jatropha Multifida Linn. Ethanol Extract And Its Fraction On High Fat Diet And Streptozotocin Induced Diabetic Nephropathy In Rats
  • 1Shri Sai College Of Pharmacy, Handia, Prayagraj, Uttar Pradesh, India
    2Lucknow Institute Of Pharmacy, Lucknow, Uttar Pradesh, India
     

Abstract

The present investigation has been carried out on leaves of Jatropha multifida Linn. The effect of ethanol leaf extract (JMEE) and its hexane fraction (JMHF) were investigated in HFD and STZ (40 mg/kg) induced diabetic rats and its histopathological study in the kidney tissues. Under histopathological analysis, the diabetic rat’s proximal convoluted tubules showed tubular necrosis with loss of their brush boundary, glomerular enlargement, interstitial space infiltration by lymphocytes, and thickening of the basement membrane. Jatropha multifida extracts lowered blood glucose level. While out of the two, maximum reduction was seen in JMHF at 200 mg/kg. The result of the present study is also justified by histopathological examinations of the kidney. This may be due to the active phytoconstituents isolated from the fraction of the 50% ethanol extract of the leaves. Phytochemical analysis of extract and fraction indicated high concentrations of flavonoids, phenolic acid and saponins. The kidney of the diabetic rats was observed to nearly return to its normal histological architecture after treatment with JMHF and can therefore be employed as a substitute medication to treat Type 2 diabetes and associated nephro-complications.

Keywords

Diabetes mellitus; Jatropha multifida; Nephropathy; Blood glucose level; High Fat Diet; Streptozotocin.

Introduction

Diabetes is a metabolic disorder with severe repercussions for an individual's well-being. It is now known to be the primary cause of long-term renal failure, with many diabetics developing end-stage renal disease and needing dialysis or organ replacement. Diabetes mellitus (DM) can lead to significant consequences, one of which is diabetic nephropathy (DN)[1].  Histologically, DN causes kidney injury that is characterized by tubular epithelial degeneration, podocyte loss, macrophage infiltration, thickening of the glomerular basement membrane, and mesangial matrix enlargement[2,3]. Furthermore, oxidative stress is caused by an imbalance between oxygen-derived radicals and the organism's antioxidant capacity. This causes oxidative damage to lipids, proteins, and nucleic acids. There have been reports that hyperglycemia in DM might cause oxidative stress, inflammation, fibrosis, and renal apoptosis[4]. More focus has recently been placed on oxidative stress as the primary cause of DN[5,6]. Genetic predisposition, elevated glucose, RAAS activation, reactive oxygen species, activation of the protein kinase C pathway, elevation of advanced glycation end-product (AGE), and glomerular hyperfiltration are some of the variables associated with diabetic ketoacidosis[7].  Currently, Insulin and oral medicines are just two of the strategies utilized to control diabetes[8,9].  However, certain treatments do have unfavorable side effects. Thus, further research is needed to develop safer and more effective anti-diabetic medications. Jatropha multifida Linn. often designated as “coral bush” is a species of Jatropha, belongs to the family Euphorbiaceae, is an endogenous plant to Tropical Americas but now extensively grown for its attractive plants and flora in Tropical to sub-tropical areas across the world. Parts of this plant are shown in Figure 1. It is easily disseminated by seeds or cuttings [10]. It is reported to contain polyphenols, flavonoids, tannins, terpenoids, alkaloids and saponins that possess anti-microbial, wound healing, anti-diabetic, anti-inflammatory and anti-oxidative properties[11, 12, 13, 14, 15,16]. Phenolic acids such as vanillic, cis and Trans ferulic, p- OH Benzoic acid, phloretic acids and glycoflavones and Flavonoids determined as Vitexin  and Isovitexin have been reported in this plant. Consequently, it is sense to assume that antioxidants will play a major role in reducing the symptoms associated with diabetes. J. multifida leaf extracts have garnered attention for their remarkable antioxidant capabilities, mostly because of the presence of substances including quercetin, kaempferol, and luteolin[15]. For example, luteolin is well known for its ability to restore antioxidant functions in kidney cells, protecting against oxidative stress[17]. Despite of this herb being used in the treatment of hyperglycemia, currently there is lack of evidence on its role in ameliorating nephro disease in DM. This study was aimed to investigate effects of JM on kidney function, kidney histopathological changes, kidney oxidative, fibrosis, inflammatory and apoptosis in DM.


       
            Picture1.jpg
       

    
       
            Picture2.jpg
       

    Figure 1. Aerial Parts And Leaf Of Jatropha Multifida Linn.


MATERIALS AND METHODS

Plant Material

Fresh leaves of J. multifida were collected from United Institute of Pharmacy, Prayagraj and were identified by Botanical Survey of India, Prayagraj (Approval No.-BSI/CRC/2021-22/435).

Animals

Adult Wistar rats (200-250gm) were taken from CPCSEA registered Laboratory Animal Supplier m/s Chakraborty Enterprises Kolkata (Registration No.- 1443/PO/Bt/S/11/CPCSEA). All rats were shifted to quarantine area for acclimatization to animal house for two weeks before the experiment. Rats resided in a control vivarium with food and water, maintaining a proper light and dark cycle. The experimental protocol was approved by the IAEC committee with Approval no. UIP/IAEC/Nov.-2021/04.

Extraction And Fractionation Of The Plant Leaves

The fresh leaves were thoroughly washed with tap water and air dried under shade at room temperature for 7 days and pulverized into coarse powder. 500 gm of the leaves were defatted using 3L of Petroleum ether by means of hot percolation and the marc obtained was dried in air and then extracted with 50% aqueous ethanol in Soxhlet apparatus. The obtained filtrate was stored in air tight container for future use. The filtrate obtained was successively fractionated using separating funnel with the following solvents in order of increasing polarity viz. n-hexane, chloroform, ethyl acetate, butanol and methanol (Figure 5). These extracts were further subjected to phytochemical testing.


       
            Picture3.jpg
       

    Figure 2. Extraction And Fractionation Of Jatropha Multifida Leaves


Detection Of Phytochemicals

The extract and fractions of J. multifida leaves were subjected to various phytochemical Screening to find out different phytoconstituents.

Pharmacological Studies

 Oral Acute Toxicity Test (LD50)

This study was conducted in animals according to OECD guidelines 423. No toxicity and death was recorded. This estimates the safe use of leaves of Jatropha multifida.

Development Of HFD

The diet was freshly prepared in the laboratory every 3rd day. Fat enriched diets have been popularly used to model obesity, dyslipidemia. Diet rich in fats easily induce type II diabetes. HFD brings about hyperinsulinemia, resistance of insulin and intolerance of glucose[18,19]. High fat diet was tested by Food Analysis & Research Laboratory, University of Allahabad. The amount of protein, fat and total sugar present in the diet was 7.38, 37.17 and 15.20 g/100g. High fat diet was given for 12 days for the induction of type 2 diabetes with the help of low dose streptozotocin and HFD was continued till the end of the experiment. List of ingredients required to make HFD are given in Table 5.


Table 5. List Of Ingredients Used To Make HFD

       
            Screenshot 2024-09-04 234511.png
       

    


Induction Of Diabetes Mellitus

On 13th day, diabetes was induced by intraperitoneal injection of STZ dissolved in citrate buffer at low dose (40 mg/kg) followed by 10% fructose solution given orally for two hours. On 16th day, fasting BGL was measured using One Touch Glucometer. Rats with BGL above 200 mg/dL were used for the study.

Dose Preparation

Suspension of JMEE and JMHF were prepared by triturating the extracts with 2% gum acacia in mortar pestle separately. Doses of JMEE were given at 200 & 400 mg per Kgbw while JMHF at doses of 100 & 200 mg per Kg.

Treatment Protocol

The diabetic rats were divided into seven groups (n=6/groups). Experimental protocol is given in Table 6. Experimental design has been followed as per Magalhães [20] which is shown in Figure 6.


Table 6. Experimental Design And Procedure


       
            Screenshot 2024-09-04 234421.png
       

    


Figure 3. Experimental Design

       
            Picture4.jpg
       

 


Analysis Of Blood Sugar Level

Blood samples were collected at the intervals of 16th, 23rd, 30th, 37th and 39th day. On 39th day, blood sample was collected through retro bulbar route in blood collecting tube. Histopathological study was done at United Diagnostic, Prayagraj, Uttar Pradesh.

Body Weight Measurement

Body weight measurement was taken at 1st, 13th, 16th, 23rd, 30th, 37th and 39th day using weighing balance.

Statistical Analysis

Data obtained were analyzed using Two Way ANOVA (Version 9.3.1) software and expressed as mean±SD followed by Dunnet’s t-test. Differences between means were regarded statistically significant below p < 0>

Histopathology Of The Kidneys

On 39th day of the experiment, the experimental rats were sacrificed by cervical dislocation method. Rats were dissected and kidney was taken out and stored in 10% formalin for histopathological evaluation. The sections were stained with haematoxylin /eosin dye using a routine protocol and examined at 40X using microscope.

RESULTS

Percentage Yield Of Extract And Its Various Fractions

The extract obtained through ethanol extraction and its fractionation were evaluated for percentage yield[21]. Percentage yield of the ethanol extract and its various fractions are mentioned in Table 1.


Table 7  Percentage Yield Of Extract And Its Various Fractions


       
            Screenshot 2024-09-04 234449.png
       

    


Phytochemical Tests

Phytochemical screening of the extract and fractions of J. multifida showed the presence of various chemical constituents. Saponins, tannins, phenolic acids, flavonoids, alkaloids are conspicuously present in large amount. Table 2 represents the result of various phytochemical tests performed.


Table 8. Phytochemical Analysis Of Jatropha Multifida Leaves Extract

 


(+) Presence; (-) Absence; (++) Abundance

 

Acute Toxicity Test

It was performed according to OECD guideline 423[22]. Animals were orally administered with JMEE and hexane fraction (JMHF) of the Jatropha multifida leaves at various doses 5, 50, 300 and 2000 and 5000 mg/Kg, separatively. No death or toxicity was recorded for both JMEE and JMHF.

Effect Of The JMEE And JMHF On Blood Glucose Level Of Glycemic Rats

The effect of ethanol extract and its hexane fraction on the BGL of glycemic rats is presented in Figure 2. Therapeutic intervention of diabetes is aimed at reducing or avoiding elevations in glucose level of blood using hypoglycemic agents or insulin. Both the ethanol extract and its hexane fraction showed significant decrease in BGL. BGL in active fraction of J. multifida ethanol extract was observed to reduce effectively as the study duration increases while the untreated glycemic rats showed geometric increase in BGL with increase in study duration. Table 3 shows the result of treatment of various doses of the extract.


Table 9. Effects Of Jmee And Jmhf On Blood Glucose Level Of Blood In Hfd And Stz-Induced Diabetic Rats


       
            Screenshot 2024-09-04 234511.png
       

    


Mean ± SD (n=6) Statistical significance in comparison to group II is ap<0>


       
            Screenshot 2024-09-04 234536.png
       

   Figure 4. Graph Representing Blood Glucose Level In Diabetes Induced Experimental Animals


Effect Of The JMEE And JMHF On Body Weight

HFD and STZ induced diabetes significantly reduces body weight of the diabetic untreated rats as the study duration increases as compared with diabetic and normal control rats (Table 4). Diabetes is accompanied with increased lipolysis, gluconeogenesis, glycogenolysis and all of these biochemical activities result in muscle wasting and loss of tissue protein. Jatropha multifida is seen to prevent such changes by restoring body weight of the diabetic treated rats. Findings showed that the oral administration of Metformin (100 mg per Kg), JMEE (200 and 400 mg per Kg), JMHF (100 & 200 mg per Kg) to diabetic rat is improved. Treatment with ethanol extract in rats has shown prominent results in restoring body weight but the effects were more pronounced with JMHF (Figure 3). This improvement may be due to control in hyperglycemic condition.


Table 4. Effects Of Jmee And Jmhf On Body Weight Of Rats

       
            Screenshot 2024-09-04 234635.png
       

    


Mean ± SD (standard deviation) for 6 experimental animals in each group. Statistical significance in comparison to Diabetic Control (ap<0>

Histopathological Assessment Of Kidney

Group I shows that glomeruli appeared normal with normal renal corpuscles, central veins, sinusoids with tubules being lined by single layer of cuboidal cells (Figure 4). Deformity of renal corpuscles, atrophy of glomeruli capillaries with perivascular edema, fibrosis were seen in Group II. The normal architecture was restored to the same as that of normal control in Group III. Central veins, portal triads and sinusoids appeared normal. Group IV shows degenerated cytoplasmic regions with mild edema, fibrosis and infiltration by lymphocytes, plasma cells and glomeruli. The normal architecture was restored similar to Group III treated kidney in Group V. Moderate increase in mesangial cellularity and matrix was seen. Histopathological examination of Group VI shows mild edema with normal glomeruli. The tubules represent cloudy swelling of the columnar cells. Minutely examined Group VII shows normal corpuscle and glomeruli with marked protection against diabetic changes.


       
            Picture5.png
       

    Figure 5. Histopathology Of Kidney


DISCUSSION

Leaves of Jatropha multifida has shown to be a potential agent for the treatment of DM, restoration of body weight and improvement of renal profile of diabetic treated rats. Thus, having a protective role on complications associated with diabetes which may be due to the presence of flavonoids, saponins or phenolic acids. Treatment with Jatropha multifida was found to almost restore the normal histopathological architecture of kidney of STZ-induced diabetic rats. Additional research is being conducted to identify and characterize the active ingredient and to better understand the mechanism underlying the anti-diabetic action. This study suggests that extract of Jatropha multifida besides its hypoglycemic activity can prevent the kidney impairment caused by diabetes. Many studies have also reported the relationship of sex hormones with the progression of Diabetic renal disease. However, the exact mechanism remains unclear[23,24]. Results of this study showed that treatment with J. multifida extract can protect the kidney tissue against tissue damage which is induced by oxidative stress related to diabetes. Increasing the number of glomeruli in diabetic rats may be due to the presence of antioxidant compounds of the plant[25,26] .  Nevertheless, more research on J. multifida is required in order to determine the active principles underlying its nephroprotective effect in diabetes, as per our findings.

CONCLUSION

The study's data demonstrated that, in contrast to the greatly raised blood glucose levels in the diabetic control rats, JMHF had significant antihyperglycemic action that may return the blood glucose levels of diabetic rats to nearly normal. Additionally, the research revealed that untreated DM might cause hyperglycemia in diabetic rats, as well as decreased renal functioning and dyslipidemia. JMHF treatment significantly reduced the negative effects of diabetes on body weight and haematological markers in diabetic rats. These results imply that JMHF therapy could improve the physiological and biochemical processes in a diabetic state, which may be essential for the management of diabetes.

ACKNOWLEDGEMENTS:

The authors thank all the faculties of Shri Sai College of Pharmacy, Lucknow Institute Of Pharmacy and all the non teaching staff for their kind support.

AUTHOR CONTRIBUTIONS:

Concept – S.S.; Supervision – S.T.; Resources – S.T.; Materials – S.S., S.T.; Data Collection and / or Processing – S.T., S.S.; Analysis and/or Interpretation – S.S.; Literature Search – S.S., S.T.; Writing – S.S., S.T.; Critical Reviews – S.T.

CONFLICT OF INTEREST STATEMENT: The authors declared no conflict of interest.

REFERENCES

  1. Tziomalos K, Athyros VG: Diabetic nephropathy: new risk factors and improvements in diagnosis. The review of diabetic studies: RDS. 2015;12(1-2):110.
  2. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. Diabetes in America. 1995;2(1).
  3. Roshan B, Stanton RC. A story of microalbuminuria and diabetic nephropathy. Journal of nephropathology. 2013 Oct;2(4):234.
  4. Kumar Arora M, Kumar Singh U. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. Current drug targets. 2014 May 1;15(5):531-8.
  5. Small DM, Morais C, Coombes JS, Bennett NC, Johnson DW, Gobe GC. Oxidative stress-induced alterations in PPAR-? and associated mitochondrial destabilization contribute to kidney cell apoptosis. American Journal of Physiology-Renal Physiology. 2014 Oct 1;307(7):F814-22.
  6. Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. American journal of physiology-renal physiology. 2005 Nov;289(5):F1040-7.
  7. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-? as the major mediator. Journal of the American Society of Nephrology. 2004 Jan 1;15(1_suppl):S55-7.
  8. Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J diabetes metab. 2015 May 1;6(5):1-9.
  9. Alhadramy MS. Diabetes and oral therapies: a review of oral therapies for diabetes mellitus. Journal of Taibah University Medical Sciences. 2016 Aug 1;11(4):317-29.
  10. Kirtikar KR and Basu BD. Indian Medicinal Plants, International Book Distributors, Second Edition, Vol III, 2005, 2243-2244.
  11. Tripathi S, Mukerjee A, Gupta N. Phytochemical screening and anti-hyperglycemic effect of Jatropha multifida L. ethanol extract and its fraction on a high-fat diet and Streptozotocin-induced diabetic rats, 2023,14(3),391-401.
  12. Poerwaningsih EH, Jusuf AA, Freisleben HJ, Sadikin M. Effects of Methanolic Jatropha multifida L. Extract in wound healing assessed by the total number of PMN leukocytes and fibroblasts. Makara Journal of Science. 2013 Mar 20:178-82.
  13. Mina EC, Ibarra MR, Franzblau SG, Aguinaldo AM. 05. Chemical and anti-tubular screening on the leaves of Jatropha multifida Linn. Pure and Applied Biology (PAB). 2021 Oct 17;2(1):32-6.
  14. Falodun A, Imieje V, Erharuyi O, Joy A, Langer P, Jacob M, Khan S, Abaldry M, Hamann M. Isolation of antileishmanial, antimalarial and antimicrobial metabolites from Jatropha multifida. Asian Pacific journal of tropical biomedicine. 2014 May 1;4(5):374-8.
  15. Carvalho C, Mariano LV, Negrão VS, Gonçalves P, Marcucci C. Phenols, flavonoids and antioxidant activity of Jatropha multifida L. collected in Pindamonhangaba, Sao Paulo State, Brazil. J Anal Pharm Res. 2018 Sep 16;7(5):581-4.
  16. Thomas S. Pharmacognostic and phytochemical constituents of leaves of Jatropha multifida Linn. and Jatropha podagrica Hook. Journal of pharmacognosy and phytochemistry. 2016;5(2):243-6.
  17. Dah-Nouvlessounon D, Chokki M, Agossou EA, Houédanou JB, Nounagnon M, Sina H, Vulturar R, Heghes SC, Cozma A, Mavoungou JF, Fodor A. Polyphenol Analysis via LC-MS-ESI and Potent Antioxidant, Anti-Inflammatory, and Antimicrobial Activities of Jatropha multifida L. Extracts Used in Benin Pharmacopoeia. Life. 2023 Sep 12;13(9):1898.
  18. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. Journal of diabetes investigation. 2014 Jul;5(4):349-58.
  19. Rosholt MN, King PA, Horton ES. High-fat diet reduces glucose transporter responses to both insulin and exercise. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1994 Jan 1;266(1):R95-101.
  20. Magalhães DA, Kume WT, Correia FS, Queiroz TS, Neto A, Edgar W, SANTOS MP, KAWASHITA NH, FRANÇA SA. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. Anais da Academia Brasileira de Ciências. 2019 Mar 21;91:e20180314.
  21. Khandelwal K R. Practical Pharmacology techniques and experiments. 20th ed, Nirali Prakashan, Pune 2010, pp-245-255.
  22. OECD Guideline Number. 423 for the Testing of Chemicals: Revised Draft Guideline 423 (Acute Oral Toxicity). 2000.
  23. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990 Sep 1;39(9):1116-24.
  24. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy. 2005 Aug 1;59(7):365-73.
  25. Hueper K, Hartung D, Gutberlet M, Gueler F, Sann H, Husen B, Wacker F, Reiche D. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on Intrarenal diffusion and oxygenation measured by magnetic resonance imaging. American Journal of Physiology-Renal Physiology. 2013 Nov 15;305(10):F1428-35.
  26. Proença C, Ribeiro D, Freitas M, Fernandes E. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of ?-amylase and ?-glucosidase activity: a review. Critical Reviews in Food Science and Nutrition. 2022 Apr 21;62(12):3137-207.

Reference

  1. Tziomalos K, Athyros VG: Diabetic nephropathy: new risk factors and improvements in diagnosis. The review of diabetic studies: RDS. 2015;12(1-2):110.
  2. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. Diabetes in America. 1995;2(1).
  3. Roshan B, Stanton RC. A story of microalbuminuria and diabetic nephropathy. Journal of nephropathology. 2013 Oct;2(4):234.
  4. Kumar Arora M, Kumar Singh U. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. Current drug targets. 2014 May 1;15(5):531-8.
  5. Small DM, Morais C, Coombes JS, Bennett NC, Johnson DW, Gobe GC. Oxidative stress-induced alterations in PPAR-? and associated mitochondrial destabilization contribute to kidney cell apoptosis. American Journal of Physiology-Renal Physiology. 2014 Oct 1;307(7):F814-22.
  6. Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. American journal of physiology-renal physiology. 2005 Nov;289(5):F1040-7.
  7. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-? as the major mediator. Journal of the American Society of Nephrology. 2004 Jan 1;15(1_suppl):S55-7.
  8. Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J diabetes metab. 2015 May 1;6(5):1-9.
  9. Alhadramy MS. Diabetes and oral therapies: a review of oral therapies for diabetes mellitus. Journal of Taibah University Medical Sciences. 2016 Aug 1;11(4):317-29.
  10. Kirtikar KR and Basu BD. Indian Medicinal Plants, International Book Distributors, Second Edition, Vol III, 2005, 2243-2244.
  11. Tripathi S, Mukerjee A, Gupta N. Phytochemical screening and anti-hyperglycemic effect of Jatropha multifida L. ethanol extract and its fraction on a high-fat diet and Streptozotocin-induced diabetic rats, 2023,14(3),391-401.
  12. Poerwaningsih EH, Jusuf AA, Freisleben HJ, Sadikin M. Effects of Methanolic Jatropha multifida L. Extract in wound healing assessed by the total number of PMN leukocytes and fibroblasts. Makara Journal of Science. 2013 Mar 20:178-82.
  13. Mina EC, Ibarra MR, Franzblau SG, Aguinaldo AM. 05. Chemical and anti-tubular screening on the leaves of Jatropha multifida Linn. Pure and Applied Biology (PAB). 2021 Oct 17;2(1):32-6.
  14. Falodun A, Imieje V, Erharuyi O, Joy A, Langer P, Jacob M, Khan S, Abaldry M, Hamann M. Isolation of antileishmanial, antimalarial and antimicrobial metabolites from Jatropha multifida. Asian Pacific journal of tropical biomedicine. 2014 May 1;4(5):374-8.
  15. Carvalho C, Mariano LV, Negrão VS, Gonçalves P, Marcucci C. Phenols, flavonoids and antioxidant activity of Jatropha multifida L. collected in Pindamonhangaba, Sao Paulo State, Brazil. J Anal Pharm Res. 2018 Sep 16;7(5):581-4.
  16. Thomas S. Pharmacognostic and phytochemical constituents of leaves of Jatropha multifida Linn. and Jatropha podagrica Hook. Journal of pharmacognosy and phytochemistry. 2016;5(2):243-6.
  17. Dah-Nouvlessounon D, Chokki M, Agossou EA, Houédanou JB, Nounagnon M, Sina H, Vulturar R, Heghes SC, Cozma A, Mavoungou JF, Fodor A. Polyphenol Analysis via LC-MS-ESI and Potent Antioxidant, Anti-Inflammatory, and Antimicrobial Activities of Jatropha multifida L. Extracts Used in Benin Pharmacopoeia. Life. 2023 Sep 12;13(9):1898.
  18. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. Journal of diabetes investigation. 2014 Jul;5(4):349-58.
  19. Rosholt MN, King PA, Horton ES. High-fat diet reduces glucose transporter responses to both insulin and exercise. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1994 Jan 1;266(1):R95-101.
  20. Magalhães DA, Kume WT, Correia FS, Queiroz TS, Neto A, Edgar W, SANTOS MP, KAWASHITA NH, FRANÇA SA. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. Anais da Academia Brasileira de Ciências. 2019 Mar 21;91:e20180314.
  21. Khandelwal K R. Practical Pharmacology techniques and experiments. 20th ed, Nirali Prakashan, Pune 2010, pp-245-255.
  22. OECD Guideline Number. 423 for the Testing of Chemicals: Revised Draft Guideline 423 (Acute Oral Toxicity). 2000.
  23. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990 Sep 1;39(9):1116-24.
  24. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy. 2005 Aug 1;59(7):365-73.
  25. Hueper K, Hartung D, Gutberlet M, Gueler F, Sann H, Husen B, Wacker F, Reiche D. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on Intrarenal diffusion and oxygenation measured by magnetic resonance imaging. American Journal of Physiology-Renal Physiology. 2013 Nov 15;305(10):F1428-35.
  26. Proença C, Ribeiro D, Freitas M, Fernandes E. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of ?-amylase and ?-glucosidase activity: a review. Critical Reviews in Food Science and Nutrition. 2022 Apr 21;62(12):3137-207.

Photo
Suchita Tripathi
Corresponding author

Assistant professor, Shri Sai College of Pharmacy Prayagraj, UP, India

Photo
Shubham Shukla
Co-author

Lucknow Institute of Pharmacy Lucknow UP India

Suchita Tripathi , Shubham Shukla , Therapeutic Effect Of Jatropha Multifida Linn. Ethanol Extract And Its Fraction On High Fat Diet And Streptozotocin Induced Diabetic Nephropathy In Rats, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 9, 242-257. https://doi.org/10.5281/zenodo.13694622

More related articles
Molecular Docking: A Powerful Tool In Modern Drug ...
Shubhangi H. Bhowate, Dr. Dinesh R. Chaple, Dr. Alpana J. asnani,...
An Overview: Vesicular carriers in cosmeceutical...
Nisha Kumari, Alok Kumar Upadhyay, Prabhudutta Panda, ...
Utilization Of Herbal Medication & Home Remedies I...
Asavari S. Dumbre, Archana T. Chaskar, Basavraj C. Hatpakki, ...
Revolutionizing NSAID Therapy: The Promise Of Mefenamic Acid Prodrugs...
Neeshma K, Digi Davis C, Rahila, Ramsiya k, Razana Binth Yoosuf P, Rubayyath K, Shafnaz Abdul Rahman...
Formulation And Evaluation Of Herbal Face Cream By Using Carrot...
V. Loganayaki, M. Subraman, R. Arulkumar, S. Sivakumar, R. Manikandan, N. Vinodhinini, ...
Analytical Method Validation of Tablet Dosage Form of Lurasidone HCl...
Dr Anu Jindal, Simranjeet Singh, Muskan Sood, Rajmeet Singh, Satvinder Kaur, Jaswinder Singh, Shavet...
Related Articles
FORMULATION & EVALUATION OF HERBAL -CREAM CONTAINING CURCUMIN FROM CURCUMA LONG...
Kalyani Sharad Khairnar , Jitesh Ravindra Desale, Mr. Mayur Sakharam Gangurde, ...
An Effective Quantitative Gas Chromatography-Head Space Method Development And V...
Radharavi K , P.D. Gokulana, K. L. Senthil Kumara, R. Ramyaa, M. Karthik, ...
Formulation And Evaluation Of Herbal FaceWash...
Abubakar Shaikh, Tejashri Kedar , Sohel Shaikh, Aman Shaikh, Devang Shah, Harsh Meher, ...
Molecular Docking: A Powerful Tool In Modern Drug Discovery And Its Approaches...
Shubhangi H. Bhowate, Dr. Dinesh R. Chaple, Dr. Alpana J. asnani, Pranita I. Rathod, Aishwarya V. Li...
More related articles
Molecular Docking: A Powerful Tool In Modern Drug Discovery And Its Approaches...
Shubhangi H. Bhowate, Dr. Dinesh R. Chaple, Dr. Alpana J. asnani, Pranita I. Rathod, Aishwarya V. Li...
An Overview: Vesicular carriers in cosmeceutical...
Nisha Kumari, Alok Kumar Upadhyay, Prabhudutta Panda, ...
Utilization Of Herbal Medication & Home Remedies In The Management Of Diabetes M...
Asavari S. Dumbre, Archana T. Chaskar, Basavraj C. Hatpakki, ...
Molecular Docking: A Powerful Tool In Modern Drug Discovery And Its Approaches...
Shubhangi H. Bhowate, Dr. Dinesh R. Chaple, Dr. Alpana J. asnani, Pranita I. Rathod, Aishwarya V. Li...
An Overview: Vesicular carriers in cosmeceutical...
Nisha Kumari, Alok Kumar Upadhyay, Prabhudutta Panda, ...
Utilization Of Herbal Medication & Home Remedies In The Management Of Diabetes M...
Asavari S. Dumbre, Archana T. Chaskar, Basavraj C. Hatpakki, ...